Drug or treatment

Dositinib clinical trials

• 2Clinical trials
• 1Country

All recruiting trials (2)

• GEN-725 plus Dositinib for EGFR-mutant non-small cell lung cancer

  This study will test whether taking GEN-725 together with Dositinib is safe and may help adults with advanced EGFR-mutant non-small cell lung cancer.

  Recruiting Phase 1/2 Henan Genuine Biotech Co., Ltd. · Beijing and 4 other locations · NCT07362940

• Dositinib dose-escalation and expansion for advanced EGFR‑mutant non-small cell lung cancer

  This trial tests whether the EGFR inhibitor dositinib is safe and active for adults with locally advanced or metastatic non‑small cell lung cancer that has EGFR mutations.

  Recruiting at 4 sites Phase 1/2 Henan Genuine Biotech Co., Ltd. · Beijing and 4 other locations · NCT07231068

Quick answers

How many clinical trials of Dositinib are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →